ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

In Congress: Continuing Resolutions Keep Feds Running; Henney Nomination Stalled By Nickles

October 16, 1998

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

In Brief: Radiation Therapy Pioneer Juan Del Regato Dead At 90

July 16, 1999

In Brief: Junqueira Of Brazil Named Next UICC President, Murphy Gets Another Term as Secretary General

September 5, 1980

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

June 10, 1994